← Back to all trials
Completed
NCT07580911
Efficacy and Safety of HA35 Gel for Ultra-Rapid Skin Pruritus Relief
Conditions: Skin Pruritus, Itch, Eczema Itch, Neurodermatitis, Insect Bite Itch, Urticaria, Postoperative Wound Pruritus
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 30
Sponsor: Nakhia Impex LLC
Location: Qingdao Hynaut Laboratory Qingdao Shandong
Summary
This is a prospective, single-arm, open-label, pilot clinical study to evaluate the efficacy and safety of topical 10% high-concentration 35 kDa hyaluronan (HA35) gel for ultra-rapid relief of moderate-to-severe skin pruritus from diverse etiologies (eczema, neurodermatitis, insect bites, urticaria, postoperative wound itch). Eligible participants will receive a single topical application of HA35 gel. The primary objective is to assess pruritus relief at 10 seconds, 45 minutes, 8 hours, 12 hours, and 24 hours post-application. Safety and local skin tolerability will be evaluated throughout the observation period. This is a minimal-risk, non-pharmacological, non-invasive intervention.
Eligibility Criteria
Inclusion Criteria:
* Age 18-65 years, male or female
* Moderate-to-severe skin pruritus (NRS ≥6) due to eczema, neurodermatitis, insect bites, urticaria, or postoperative wound itch
* Able to understand and complete NRS assessments independently
* Signed written informed consent
Exclusion Criteria:
* Topical corticosteroid/antihistamine use within 2 weeks
* Infected, broken, or exudative skin lesions at the application site
* Known hypersensitivity to hyaluronan or gel components
* Severe systemic disease or immune dysfunction
* Pregnant or lactating women
Source: ClinicalTrials.gov (NCT07580911). StuddyBuddy aggregates publicly available trial information.